Literature DB >> 11543986

Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry.

D John1, C F Kwiatkowski, R E Booth.   

Abstract

The goal of this study was to compare drug and alcohol use, psychological symptoms and substance abuse treatment entry among 583 street-recruited, out-of-treatment injection drug users (IDUs) who used stimulants only, opiates only or both stimulant and opiate. Data analyzed from structured interviews indicated that stimulant-only users had the most severe alcohol problems and the highest psychological symptom scores for hostility, paranoia and psychoticism. In the 2 months following their interview only 3% of the stimulant-only users entered substance abuse treatment, as compared to nearly half of the participants in the other two groups. Even after controlling for variables that differed among the groups by logistic regression analysis, stimulant only users were still 24-25 times less likely than opiate only or both stimulant and opiate users to enter treatment. Researchers and clinicians are challenged to better understand and address the unique needs of stimulant users, including potential psychological problems and alcohol abuse, in order to attract them to treatment and serve them through a comprehensive treatment approach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543986     DOI: 10.1016/s0376-8716(01)00120-x

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  Injection drug use among stimulant users in a national sample.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; Wendee M Wechsberg; William E Schlenger
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

2.  Reducing HIV-related risk behaviors among injection drug users in residential detoxification.

Authors:  Robert E Booth; Barbara K Campbell; Susan K Mikulich-Gilbertson; Carrie J Tillotson; Dongseok Choi; James Robinson; Donald A Calsyn; Raul N Mandler; Lindsay M Jenkins; Laetitia L Thompson; Catherine L Dempsey; Michael R Liepman; Dennis McCarty
Journal:  AIDS Behav       Date:  2011-01

Review 3.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

4.  The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.

Authors:  Barak Shapira; Paola Rosca; Ronny Berkovitz; Igor Gorjaltsan; Yehuda Neumark
Journal:  PeerJ       Date:  2020-07-17       Impact factor: 2.984

5.  Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.

Authors:  Yih-Ing Hser; Elizabeth Evans; David Huang; Robert Weiss; Andrew Saxon; Kathleen M Carroll; George Woody; David Liu; Paul Wakim; Abigail G Matthews; Mary Hatch-Maillette; Eve Jelstrom; Katharina Wiest; Paul McLaughlin; Walter Ling
Journal:  Addiction       Date:  2016-01-13       Impact factor: 6.526

6.  Heroin and cocaine co-use in a group of injection drug users in Montréal.

Authors:  Francesco Leri; Jane Stewart; Annie Tremblay; Julie Bruneau
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

7.  Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.

Authors:  Linwei Wang; Jeong Eun Min; Emanuel Krebs; Elizabeth Evans; David Huang; Lei Liu; Yih-Ing Hser; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2017-09-06

8.  Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users.

Authors:  Mary-Lynn Brecht; David Huang; Elizabeth Evans; Yih-Ing Hser
Journal:  Drug Alcohol Depend       Date:  2008-03-10       Impact factor: 4.492

9.  Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse.

Authors:  Miranda G Greiner; Matisyahu Shulman; Tse-Hwei Choo; Jennifer Scodes; Martina Pavlicova; Aimee N C Campbell; Patricia Novo; Marc Fishman; Joshua D Lee; John Rotrosen; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2021-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.